Genomma Lab Internacional Stock Price, News & Analysis (OTCMKTS:GNMLF) $0.84 0.00 (0.00%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.84▼$0.8450-Day Range$0.73▼$0.8552-Week Range$0.73▼$0.86VolumeN/AAverage Volume1,656 shsMarket CapitalizationN/AP/E Ratio0.49Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest About Genomma Lab InternacionalGenomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.Read More GNMLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNMLF Stock News HeadlinesOctober 4, 2023 | prnewswire.comGenomma Lab Internacional S.A.B. de C.V. Third Quarter 2023 Earnings Results Conference CallSee More Headlines Receive GNMLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genomma Lab Internacional and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNMLF CUSIPN/A CIKN/A Webwww.genommalab.com Phone525550810000FaxN/AEmployees2,388Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.49 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Juan Marco SparvieriChief Exec. OfficerEngineer Antonio Zamora GallandExec. VP of Fin. & Admin. and CFODaniel Suarez NeriaHead of Investor RelationsMr. Alejandro Bastón PatiñoExec. VP of Institutional Relations, Media, HR & SustainabilityKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors GNMLF Stock Analysis - Frequently Asked Questions Should I buy or sell Genomma Lab Internacional stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Genomma Lab Internacional in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GNMLF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNMLF, but not buy additional shares or sell existing shares. View GNMLF analyst ratings or view top-rated stocks. How have GNMLF shares performed in 2023? Genomma Lab Internacional's stock was trading at $0.84 at the beginning of 2023. Since then, GNMLF stock has decreased by 0.0% and is now trading at $0.8399. View the best growth stocks for 2023 here. Are investors shorting Genomma Lab Internacional? Genomma Lab Internacional saw a increase in short interest in November. As of November 15th, there was short interest totaling 3,477,700 shares, an increase of 16.0% from the October 31st total of 2,997,200 shares. Based on an average trading volume of 1,000 shares, the days-to-cover ratio is presently 3,477.7 days. View Genomma Lab Internacional's Short Interest. How do I buy shares of Genomma Lab Internacional? Shares of GNMLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:GNMLF) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genomma Lab Internacional, S.A.B. de C.V. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.